TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT06297525: Study of STP938 (Dencatistat) in Advanced Solid Tumours

Sponsor: Step Pharma, SAS · Phase: PHASE1 · Area: ONCOLOGY · Target Enrollment: 70 pts

Competing Trials Overlap

6 Active Trials

Excess Burn Exposure

$376,992

Rescue Site Savings

+$251,328

Unlock Full NCT06297525 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06297525 Rescue Dossier →